Lexaria Bioscience Corp. (LEXX)

NASDAQ: LEXX · Real-Time Price · USD

Compare

0.5600

-0.0600 (-9.68%)

At close: Dec 24, 2025, 1:00 PM EST

0.5557

-0.0043 (-0.77%)

After-hours: Dec 24, 2025, 4:59 PM EST

Lexaria Bioscience Income Statement

Financials in millions USD. Fiscal year is September - August.

Millions USD. Fiscal year is Sep - Aug.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021	2016 - 2020
Revenue	0.71	0.46	0.23	0.26	0.72	Upgrade
Revenue Growth (YoY)	52.05%	105.24%	-11.43%	-64.66%	129.59%	Upgrade
Cost of Revenue	0	0	0.03	0.07	0.18	Upgrade
Gross Profit	0.7	0.46	0.19	0.18	0.55	Upgrade
Selling, General & Admin	4.1	3.79	2.96	4.96	4.97	Upgrade
Research & Development	8.24	2.36	3.67	1.84	1.26	Upgrade
Operating Expenses	12.34	6.15	6.62	6.8	6.23	Upgrade
Operating Income	-11.63	-5.7	-6.43	-6.62	-5.69	Upgrade
Interest & Investment Income	0	0.01	0.04	-	-	Upgrade
EBT Excluding Unusual Items	-11.63	-5.68	-6.38	-6.62	-5.69	Upgrade
Gain (Loss) on Sale of Investments	-0.03	-0.07	-0.22	-0.76	-	Upgrade
Asset Writedown	-0.25	-0.06	-0.11	-	-	Upgrade
Pretax Income	-11.91	-5.81	-6.71	-7.38	-5.69	Upgrade
Earnings From Continuing Operations	-11.91	-5.81	-6.71	-7.38	-5.69	Upgrade
Earnings From Discontinued Operations	-	-	-	-	1.5	Upgrade
Net Income to Company	-11.91	-5.81	-6.71	-7.38	-4.19	Upgrade
Minority Interest in Earnings	0.01	0.01	0.05	0.11	0.16	Upgrade
Net Income	-11.9	-5.8	-6.66	-7.27	-4.03	Upgrade
Net Income to Common	-11.9	-5.8	-6.66	-7.27	-4.03	Upgrade
Shares Outstanding (Basic)	18	12	7	6	4	Upgrade
Shares Outstanding (Diluted)	18	12	7	6	4	Upgrade
Shares Change (YoY)	45.34%	87.24%	12.38%	34.02%	58.34%	Upgrade
EPS (Basic)	-0.66	-0.47	-1.01	-1.24	-0.92	Upgrade
EPS (Diluted)	-0.66	-0.47	-1.01	-1.24	-0.92	Upgrade
Free Cash Flow	-10.48	-5	-5.91	-4.93	-3.99	Upgrade
Free Cash Flow Per Share	-0.58	-0.40	-0.89	-0.84	-0.91	Upgrade
Gross Margin	99.61%	98.96%	86.08%	71.87%	75.74%	Upgrade
Operating Margin	-1647.97%	-1226.70%	-2841.31%	-2591.67%	-786.85%	Upgrade
Profit Margin	-1686.00%	-1248.25%	-2946.36%	-2846.28%	-557.19%	Upgrade
Free Cash Flow Margin	-1483.88%	-1077.38%	-2614.84%	-1929.75%	-552.02%	Upgrade
EBITDA	-11.55	-5.62	-6.28	-6.52	-5.58	Upgrade
D&A For EBITDA	0.09	0.08	0.15	0.1	0.11	Upgrade
EBIT	-11.63	-5.7	-6.43	-6.62	-5.69	Upgrade

Updated Aug 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q